specific protection breast cancers cyclin d1 ablation
breast cancer common malignancy among women cancers overexpress cyclin d1 component core cell-cycle machinery previously generated mice lacking cyclin d1 using gene targeting report cyclin d1-deficient mice resistant breast cancers induced neu ras oncogenes however animals lacking cyclin d1 remain fully sensitive oncogenic pathways mammary epithelium driven c-myc wnt- analyses revealed mammary epithelial cells neu-ras pathway connected cell-cycle machinery cyclin d1 explaining absolute dependency cyclin d1 malignant transformation tissue results suggest anti-cyclin d1 therapy might highly specific treating human breast cancers activated neu-ras pathways
